Abstract
Introduction
Pseuda llesch eria boydii-a ubiquitous ,saprophytic fungus in the class Ascomycetes-is an emerging pathogen found worldwide. It is commonly isolated in soil, in polluted and coastal waters, and in animal manure. I Siebenmann first isola ted the organism in the 1880s as a pathogen in the ear of a child with chronic otitis externa. ' The first complete description of the organism was published in 1922 by Shear.' P boydii is associated with Madura foot (maduromycosis) , a cutaneous and subcutaneous suppurative dise ase that affec ts farmers in trop ical and subtropical countries.' Historically, Madura foot has accounted for 99% of all P boydii infections.' The organism has also been identified in specimens obtained from pulmo nary cavities and pulmonary infiltrates. It has been shown to cause sinusitis, corneal infections, endophthalmitis, parotitis, skin infections, arthritis , osteomyelitis , brain and thyroid abscesses, endocarditis, chronic prostatitis, and disseminated infection. ' In this article, we describe a case of P boydii inva sive fungal sinusitis in a diabetic patient who died before the pathogen was ident ified. As we discuss , this organism can be mistaken for Aspergillus on fungal smear, but it is typically resistant to ampho tericin B, the antifu ngal medication that is commonly started empirically for patients with invasive funga l sinusitis. Thus, in cases of invasive fungal sinusitis, proper identification via culture is imperative to ensure effective pharmacotherapy.
Case report
A 76-year-old man with non-ins ulin-dependent (type 2) diabete s mellitus presented with a 4-mo nth history of intractable temporal and occipital headaches. Since the onset of the headaches, he had been diagnosed with sinusitis and treated twice with a penicillin derivative, but his headaches did not reso lve. Two subsequent courses of a steroid taper prov ided no relief. At that poi nt, the patien t was admitted to our hospital for a further workup.
Upon admission, the patien t was dehydrated and hyperglycemic; a finger-stick blood test revealed that his glucose level was 477 mg/dl. He had discontinued his oral hypoglycemic medication prior to admission, despite being on a steroid course. The early part of his hospitalization was complicated by the medical and later surgical treatment of diverticulitis . After one of his abdominal surgeries, he awoke from surgery confused and combative and comp laining of blindness in both eyes. Prior to the onset of the blindness, the patient's visual acuity had been 20/60 in the right eye and 6/200 in the left eye; he had also had a left relative affere nt pupillary defec t. However, after the onset of the blindness, he was found to have a disconjugate gaze with poor extraocular motility (worse in the left eye), and he was not able to perceive hand movements in front of his eyes .
The laboratory workup revea led an elevated white blood cell (WBC) count of 12.6 x 109/L (normal: 4.8 to 10.8), an elevated erythrocyte sedime ntation rate of81 mm/hr( normal: 0 to 20), and an elevated glycosy lated hemoglobin concentration of 11.2% (normal: 4.5 to 6.4 %). Th e rapid plasma reagin test was nonr eacti ve, and the vitamin B I2 level was elevate d at 1,143 pg/ml (nor ma l: 21Oto 705 ).Alumbar puncture revealed a low cerebrospinal fluid (CSF) glucose conc entr ation of 104 mg/dl (norma l: 239 to 358 for a blood glucose level of477 mg/dl ) and an elevated CSF protein level of 49. 2 mg/dl (normal: 15 to 45 ); no WBC s were found in the CSF.
Non contrast computed tom ography (CT) of the head showed a partial opacification at the sphenoid sinus. Contrast-enh anced magnetic resonance imaging (MRI) ofthe brain demonstrated enhance ment of the dura along the planum sphenoidale, the anterior frontal lobes bilaterally, and the orbital apices bilate rally (figure I). Enh ancement was also noted along the anterior clinoid. Bilateral engorgement of the superior orbital veins was noted .
Nasal endosco py detected no necrosis of any turbin ate or of the rostra of the sphenoid sinuses (figure 2). Contrast-enhanced CT of the sinuses revealed mucoperiosteal thick enin g of the right sphenoid and front al sinuses and opacification of the left sphenoid sinus (figure 3). Enh ancing soft tissue was seen at the posterior wall of the frontal sinus, and it extended along the planum sphenoidale and through the fovea ethmoidalis; intracranial extension was seen along the dura at the anterior cranial fossa and the anterior aspect of the interhem ispheric falx (figure 4). Additionally, the process extended anteriorly throu gh the optic nerve foramina and superior orbital fissure s and was assoc iated with a loss of norm al fat plane s bilaterall y in the pterygopal atin e fossae. Bone erosion accompanied the abnormal soft-tissue extension from the ethmoid air cell s and frontal sinuses throu gh the adjacent anterior cra nial floor and cr ibriform plate.
In light of these findings, the patient was placed on emp iric pip eracill in/t azobact am and ampho tericin B lipid complex to cover bacterial skull base osteomyelitis and invasive funga l sinusitis. He was then taken to the opera ting room for image -guided bilateral end oscopic sphenoidotomy with biopsy. Operativ e findings included minim ally inflamed mucosa within the nasal cavity. No necrotic tissue was present on the right or left sphenoid rostrum, and no purulent or necrotic debris was present in either sphenoid sinus (figure 5). A frozen-section biop sy of the right sphenoid sinus was repo rted as only inflamed mucosa with no evidence of inva sive fungal disease. A
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Gram 's stain of the sinus contents identified gra m-positive cocci and yeas t. Fin al pathology identifi ed a mass of fungal hyph ae in I of 5 specimens that were morphologicall y consistent with the presence of Asperg illus spp. Culture grew 2+ coagulase-negative staphy lococci and 1+ multidrug-resistant Klebsiella pneum onia e. Based on these findings, the antibac terial coverage was changed to vanco myc in and merop enem .
Over the next several days, the patient's ment al status worsened. A cerebral angiogram showed an area of opacificati on within the anter ior aspect of the left ca vernou s sinus consistent with thrombosis. Henc e, the patient was started on heparin anticoagulation. However, his ment al status continued to wor sen, and he developed epistaxis that required packing of the left nasal cavity. The heparin drip was discontinued, but soo n ther eafter, he developed worsening respiratory distress and died. Of note, he had been switched from amphotericin B lipid complex to voriconazole approximately 3 days prior to his death because the maximum amphotericin B dosage had been reached.
At autopsy, the dura of the anterior falx cerebri was indurated and thickened (as much as 0.5 ern). Micro scopic examination of this area detected acute and chronic inflammation associated with necrosis and a granulomatous component. Silver stains showed septate fungal hyphae. Fungal cultures from the sphenoid biopsies performed at surgery grew P boydii in the postmortem period.
invasive disease, 9 were immunocompromised; 4 patients had leukemia, 3 were diabetics, and 2 had acquired immunodeficiency syndrome (AIDS). All 9 of these patients either died of infection or another cause or had persistent or recurrent infection at the time the case was reported. Six of these 9 immunocompromised patients were treated with surgery and antifungal therapy, 1 was treated with surgery and antibacterial therapy, and 2 were treated with antifungal therapy alone. Of the 3 immunocompetent patients with proven or suspected invasive disease, I experienced a complete resolution of disease after undergoing combined
Literature review
For our literature review, we searched the PubMed database, using the keywords Pseudallescheria, boydii, verticillium graphii, Allescheria , Gl enospora , Indiella americanus, A cremoniella Ius ii , Petriellidium, Scedosporiutn apiospermum, monosporium, and sinusitis. We found 25 reported cases of sinus itis that were caused by P boydii.r" The case described in this article brings to 26 the total number of cases documented in the literature (table). These patients included 17 women and 9 men, aged 20 to 85 year s (mean : 48.3). The first case was reported by Gluckman et al in 1977; their patient was a 58-yearold diabetic man on hemodialysis who ultimately died of a cause unrelated to his P boydii infection ."
Of the 26 cases, mucosal invasion by fungal organisms was proven or suspected in 12 patients , excluded or not suspected in 9 patients , and unknown in the remaining 5 patients. Of the 12 patients with proven or suspected surgery and antifungal therapy, 1 responded completely to surgery alone , and 1 died of infection after being treated with combined surgery and antifungal therapy.
Five of the 9 patients without evidence or suspicion of invasion were immunocompetent, and all 5 experienced a complete resolution of their infection; 4 patients had been treated with surgery alone and the other with combined surgery and antifungal therapy. Of the 4 patients without signs of invasion who were immunocompromised (1 case each of adrenocortical insufficiency, sickle cell anemia, diabetes, and organ transplantation), I patient experienced a full resolution with combined surgery and antifungal therapy, 1 recovered completely with surgery alone, 1 died of squamous cell carcinoma of the sinuses following surgery, and the outcome of the other patient, who had undergone surgery, was not reported.
Among the 5 patients in whom the presence or absence of fungal invasion was not reported, 2 were immunosuppressed (1 case of diabetes and I case of bone marrow transplantation); the diabetic patient was treated with surgery alone and his outcome was not reported, and the post-transplant patient was treated with combined surgery and antifungal therapy but died of a related cause. Of the 3 immunocompetent patients in whom the presence or absence of fungal invasion was not reported, all experienced a complete resolution of symptoms; 2 had been treated with surgery alone, and I had been treated with combined surgery and antifungal therapy.
Among the 26 cases, the maxillary sinuses were involved in 15 cases, the sphenoid sinuses in 14, the ethmoid sinuses in 9, the frontal sinuses in 2, and the nasal cavity only in I. Seven of the 14 patients with sphenoid sinus involvement had isolated sphenoid disease.
Of the 26 patients, 13 had concomitant bacterial infections; these pathogens included K pneumoniae (n = 3), Staphylococcus au reus (3), Citrobacter freundii (3), Staphylococcus epidermidis (3), Proteus mirabilis (2), Enterobacter cloacae (2), anaerobic gram-positive rods (1), Serratia liquefasciens (1), and Klebsiella oxytoca (1) . Fungal coinfection (Candida albicans) was seen in 1 patient.
Discussion
Fungal infection of the paranasal sinuses includes a broad spectrum of disease processes. At one end of the spectrum is allergic fungal sinusitis, which represents an immune reaction to noninvading fungal colonizers that was first associated with Aspergillus. v At the other end of the spectrum is acute invasive fungal sinusitis, which is usually caused by Mucor or Aspergillus spp. Intermediate disease processes include chronic invasive fungal sinusitis and chronic noninvasive fungal sinusitis (fungus ball). In 1997, deShazo et al proposed that invasive fungal sinusitis be classified into three categories: granulomatous, acute fulminant, and chronic?' They described 2 cases of chronic invasive sinusitis in middle-aged adults with well-controlled non-insulin-dependent diabetes mellitus and apical orbital syndrome. The 2 patients had a similar course: protracted disease for more than 6 months with proptosis, vision changes, and late neurologic symptoms reflecting cavernous sinus invasion. Both patients died of their infection. Our patient followed a similar course with several months of protracted headache.
Aspergillus, Mucor, and Candida spp. are responsible for most pathologic fungal sinus infections." However, improvements in the medical management of immunosuppressed patients and the wider use of immunosuppressive therapies has led to the identification of a long list of unusual fungal pathogens, some of which were previously thought to be solely commensal. Specifically, rare fungal pathogens have been isolated inAIDS patients," in cancer patients (particularly those being treated for leukemia"), and in transplant recipients." One of these emerging pathogens is P boydii.
P boydii has undergone many name changes over the years. In his original report, Siebenmann called it Verticillium graphii? It has since been referred to as Allescheria boydii, Glenospora boydii, Indiella americanus, andAcremoniella lusii:" In 1970, Malloch suggested that the species be transferred from the genusAllescheria to Petriellidium.v This change was later thought to be an error, and the organism was placed in the valid and previously described genus Pseudallescheria,' The anamorph (imperfect) form of the organism is called Scedosporium apiospermum (formerly Monosporium apiospermum),and was shown by Emmons-" in 1944 to be the same organism as P boydii. Both forms have been implicated as pathogens.
Of the 26 cases':" of fungal sinusitis secondary to P boydii infection that have now been reported in the literature, fungal invasion was proven or suspec ted in 12 patient s, 9 of whom we re immunoco mpromised. It is interes ting that the other 3 patient s with invasi ve disease were immunocomp etent; 2 ex per ienced a full resolution of infec tion (l with co mbinatio n surgery and antifunga l therap y and the other with surgery alone). Amo ng the 13 patie nts with immunosuppression whose outcome was reported, I I eit her die d or had persistent or recurrent infection by the time the case was reported. Two patients with imm unos uppression experienced a complete resolution of the infection, but neither had evidence of invasion; I of these patients had been treated with com bined surgery and antifu nga l therapy and the othe r had been trea ted with surgery alone. T hese dat a suggest that our patie nt' s prognosis pro bably wo uld have bee n poo r eve n if he had been diagnose d soo ner.
Identi fication of P boydii by fungal culture is esse ntial to selecting effective pharmacoth erapy. Th e hyph ae of P boydii ca n rese mble those of Aspergillus on fungal stains, and their tropism for blood vessels is similar." But unl ike
Asperg illus, P boydii is typic ally res istant to amphotericin
Volume 85, Numbe r 11 B.37 Thi s ca n be probl em atic because amphotericin B is ofte n the first-line pharma cologic ther ap y for suspec ted invasive fungal sinusitis. Miconazole is the antifungal of choice for P boydii,3Xand seve ra l autho rs have rep orted successful trea tme nt with ketoconazo le.P't-":'? In 197 8, Cosg rove et al theorized that co mbining amphote ric in B with an imidazo le antifunga l m ight result in antago nism because the two age nts competed for the same binding sites on ce ll membranes." However, Walsh et al challenged that theory in 1995 when they reported that in vitro studies specific for P boydii showed that the two co mpou nds actually migh t have a sy nergistic re lationship. ' ? More recently, the res ults of other in vitro studies have supported the use of vor ico nazo le, a new triazol e antifu nga l agent, in the treatment of P boydii infections." :"
Our patient presented with a 4-mont h history of vag ue headach es, which are often characterist ic of chronic sphe noid sinusitis." He underwent an extensive work up, but the diagnosis was elusive. Onl y after orbital apex syndro me had developed was the diagn osis of chro nic sinusi tis with skull ba se osteo mye litis made. Even then , the organisms responsible we re not k now n. Pathologic specimens from sphenoid sinus biop sies yielded a mass of fun gal hyphae that resembled A spergillus. It was for this reason that amph otericin B was started. It was not until after the pat ient had died that P boydii was grown in cultures of the sphenoid sinus. As discussed , P boydii is typic ally resistant to amphotericin B, so this patient received inadequate pharmacologic therapy. As for surgical therapy, by the time this patient had been diagnosed , imaging had already demonstrated ero sion of a significant part of his anterior skull base and enhancement of the dura of the anterior cranial foss a. An earlier diagnosis and the use of micon azo le or vor iconazole as the initial therapy might have changed this patient's outcome. However, the literature suggests that patients with invas ive P boydii who are imm unocompromised have a high mortality rate regardless of therapy.
In conclusion, fungal sinusitis secondary to P boydii infec tion is rare. When it doe s occur, it can appear in both immunosuppressed and immunocompetent patient s. Although the organism resembles Asp ergillu s on pathologic examination, P boydii is typically resistant to amphotericin B. Therefore, culture and a definitive identification of the organism are crucial to selecting adequate pharmaco logic ther apy. Sen sitivity testing will help direct antifung al therapy. In general , patients shou ld be treated with a combination of surgery and antifunga l therapy, particularly tho se patients with immunosuppression and funga l inva sion . Immunocompetent patients with P boydii fungal sinusitis have a better prognosis, even when invasion is presen t.
